- Home
- ANL vs AKYA Comparison
ANL vs AKYA Comparison
Compare ANL & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- AKYA
- Stock Information
- Founded
- ANL 2004
- AKYA 2015
- Country
- ANL Cayman Islands
- AKYA United States
- Employees
- ANL N/A
- AKYA N/A
- Industry
- ANL
- AKYA Medical Specialities
- Sector
- ANL
- AKYA Industrials
- Exchange
- ANL Nasdaq
- AKYA Nasdaq
- Market Cap
- ANL 73.8M
- AKYA 56.1M
- IPO Year
- ANL 2023
- AKYA 2021
- Fundamental
- Price
- ANL $1.82
- AKYA $1.21
- Analyst Decision
- ANL Strong Buy
- AKYA Hold
- Analyst Count
- ANL 2
- AKYA 7
- Target Price
- ANL $9.00
- AKYA $2.51
- AVG Volume (30 Days)
- ANL 10.1K
- AKYA 1.1M
- Earning Date
- ANL 06-10-2025
- AKYA 05-12-2025
- Dividend Yield
- ANL N/A
- AKYA N/A
- EPS Growth
- ANL N/A
- AKYA N/A
- EPS
- ANL N/A
- AKYA N/A
- Revenue
- ANL N/A
- AKYA $79,961,000.00
- Revenue This Year
- ANL N/A
- AKYA $12.57
- Revenue Next Year
- ANL N/A
- AKYA $13.73
- P/E Ratio
- ANL N/A
- AKYA N/A
- Revenue Growth
- ANL N/A
- AKYA N/A
- 52 Week Low
- ANL $1.10
- AKYA $0.93
- 52 Week High
- ANL $8.88
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- ANL 45.00
- AKYA 53.73
- Support Level
- ANL $1.71
- AKYA $1.21
- Resistance Level
- ANL $2.10
- AKYA $1.32
- Average True Range (ATR)
- ANL 0.09
- AKYA 0.09
- MACD
- ANL 0.01
- AKYA 0.03
- Stochastic Oscillator
- ANL 28.21
- AKYA 62.67
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.